Results 151 to 160 of about 166,404,517 (251)

GIS express for chronic disease ; Volume 3, Issue 3, July 29, 2020

gis-express-vol3-issue3-508.pdfMaps in Action: County-level Increases in CHD Mortality -- Atlas Insights: Compare Layers of Risk and Disease -- GIS Resource: Chronic Disease Indicators -- Map Gallery Spotlight: Hypertension and Drive Times to Lifestyle ...

core  

Anaemia, hypoalbuminemia, and risk of cycloserine-associated neuropsychiatric toxicity in a shortened oral regimen for multidrug/rifampicin-resistant TB. [PDF]

IJTLD Open
Shen EQL, Rashitov M, Algozhina E, Arlyapova N, Skrahina A, LaHood A, Trevisi L, Osso E, Romo M, Seung KJ, Mitnick CD, Rich ML, Franke MF, Algozhin Y.   +13 more
europepmc   +1 more source

Clinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients

Clinical Pharmacology &Therapeutics, EarlyView.
Traditional dosing strategies often rely on a “one‐size‐fits‐all” paradigm, assuming an “average” patient with typical demographic and pharmacological characteristics. In reality, this often overlooks existing between‐patient variability and can lead to suboptimal drug exposure or toxicity. This issue is especially pronounced in pediatric patients, who
Zachary L. Taylor, Takanobu Nadai, Kei Irie, Wen Rui Tan, Sanjana Parikh, Anhar Hosawi, Matthijs W. van Hoogdalem, Ronaldo Morales Junior, Sonya Tang Girdwood, Abbie D. Leino, Kana Mizuno, Alexander A. Vinks, Tomoyuki Mizuno   +12 more
wiley   +1 more source

Addressing chronic disease through community health workers : a policy and systems-level approach [PDF]

Second edition.This document provides guidance and resources for imple- menting recommendations to integrate community health workers (CHWs) into community-based e orts to prevent chronic disease. After providing general information on CHWs in the United

core  

Plummer-Vinson syndrome in a 10-year-old boy from Côte d'Ivoire: An exceptional paediatric case with African context. [PDF]

JPGN Rep
Tayou Mbobda PM, Kouamé HGD, Ouattara A.   +2 more
europepmc   +1 more source

Model‐Informed Evaluation of Hydroxyurea Exposure During Lactation

Clinical Pharmacology &Therapeutics, EarlyView.
Hydroxyurea is a cornerstone therapy for sickle cell anemia; however, evidence guiding its use during lactation remains limited. This study aimed to develop a population pharmacokinetic (PK) model to characterize hydroxyurea disposition in maternal plasma and breast milk, and to quantify infant exposure under clinically relevant breastfeeding scenarios.
Anhar Hosawi, Kei Irie, Min Dong, Julie Ware, Russell Ware, Tomoyuki Mizuno   +5 more
wiley   +1 more source

GIS express for chronic disease ; v. 3, issue 2, May 15, 2020

gis-express-vol3-issue2-508.pdfMaps in Action: COVID-19 Dashboard from Johns Hopkins University -- GIS Epi Resource: COVID-19 Data Hub from the US Census Bureau -- Atlas Insights: New and Updated Data Now Available -- Building GIS Capacity: Chronic ...

core  

Paediatric Collagenous Gastritis with Transient Response to Steroid Therapy. [PDF]

Eur J Case Rep Intern Med
O'Connor R, Standish R, Karunadasa H, Chan R, Hodge A.   +4 more
europepmc   +1 more source

Coexistence of immunophenotypically normal and aberrant mast cells in patients with clonal mast cell diseases associates with more indolent subtypes and less severe disease characteristics

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Aberrant antigen expression on mast cells (MCs) is one of the most accurate diagnostic markers for clonal MC diseases (CMCD). Although the coexistence of normal and pathologic MCs is frequently seen, the disease characteristics associated with it have been minimally investigated.
Abdulrazzaq Alheraky, Kees Meijer, Marije Nijk, Saskia K. Klein, Hanneke N. G. Oude Elberink, Ido P. Kema, André B. Mulder   +6 more
wiley   +1 more source

Using causal frameworks to reduce bias in observational TB research: a comparison of model-building approaches. [PDF]

IJTLD Open
Barcellini L, Sauer S, Romo M, Mitnick CD, Huerga H, Khan U, Hewison C, Rich ML, Franke MF, Khan PY.   +9 more
europepmc   +1 more source